Changzheng Chen, PhD
Intra-Cellular Therapies, a Johnson & Johnson Company, Bedminster, New Jersey
- 3Articles
- 6.3KReads
- 2013–2025Active
- 12Collaborators
- 69Citations
About
Changzheng Chen, PhD is affiliated with Intra-Cellular Therapies, a Johnson & Johnson Company, Bedminster, New Jersey. Changzheng Chen has authored or co-authored 3 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2013 and 2025. Their work focuses on Depression (MDD).
Publications
Lumateperone as Adjunctive Therapy in MDD: A Randomized, Double-Blind, Phase 3 Trial
August 25, 2025
Levomilnacipran Extended-Release Treatment in Patients With Major Depressive Disorder: Improvements in Functional Impairment Categories
June 11, 2015
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.